Chugai Venture Fund
Boston, Massachusetts, United StatesFounded 2023
Chugai Venture Fund is a strategic corporate investment fund focused on fostering innovation and driving transformative advances in the life sciences industry. It invests in early-stage science and companies, particularly in pharmaceutical development, drug discovery technologies, and digital technologies, that align with Chugai Pharmaceutical's R&D efforts and aim to improve patient care.
100% of their portfolio is in Biotech & Life Sciences. Deal activity increased 100% year-over-year (2 deals in the last 12 months).
Portfolio
3
Fund Size
$200M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ten63 Therapeutics | Unknown | — | Feb 2026 |
 Dualitas Therapeutics, Inc. | Series A | $65M | Sep 2025 |
| LLeal Therapeutics, Inc. | Series B | $45M | Oct 2024 |
Top Co-Investors
Alexandria Venture Investments3 shared
Versant Ventures1 shared
Qiming Venture Partners USA1 shared
SV Health Investors1 shared
Eli Lilly and Company1 shared
Gates Foundation1 shared
K5 Global1 shared
Duke Capital Partners1 shared
Black Opal Ventures1 shared
Yosemite1 shared
Morpheus Ventures1 shared
Draper Associates1 shared
Newpath Partners1 shared
OrbiMed1 shared
Euclidean Capital1 shared
Last updated: 16 April 2026